RFERENCES

Abdissa, D. and Kene, K., 2020. Prevalence and determinants of hypertension among diabetic
patients in Jimma University Medical Center, Southwest Ethiopia, 2019. Diabetes, Metabolic
Syndrome and Obesity, pp.2317-2325.
Adeloye, D., Owolabi, E. O., Ojji, D. B., Auta, A., Dewan, M. T., Olanrewaju, T. O., … &
Adewole, I. F. (2021). Prevalence, awareness, treatment, and control of hypertension in
Nigeria in 1995 and 2020: A systematic analysis of current evidence. Journal of Clinical
Hypertension, 23(5), 963-977
Akalu, Y. and Belsti, Y., 2020. Hypertension and its associated factors among type 2 diabetes
mellitus patients at Debre Tabor general hospital, northwest Ethiopia. Diabetes, Metabolic
Syndrome and Obesity, pp.1621-1631.
Akalu, Y. and Belsti, Y., 2020. Hypertension and its associated factors among type 2 diabetes
mellitus patients at Debre Tabor general hospital, northwest Ethiopia. Diabetes, Metabolic
Syndrome and Obesity, pp.1621-1631.
Alabi A. N., Onuoha F. M., and Alabi K. M., “Awareness of obesity as a cardiovascular risk

factor among different occupational groups in a primary care clinic in Nigeria,” Nigerian

Journal of Family Practice, vol. 5, pp. 13–18, 2014.

Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017). Diabetic kidney disease: challenges,

progress, and possibilities. Clinical Journal of the American Society of Nephrology, 12(12),

2032-2045.

American Diabetes Association (ADA). (2021). Standards of Medical Care in Diabetes—2021.

Diabetes Care, 44(Supplement 1), S17-S25.

American Diabetes Association (ADA). “Standards of Medical Care in Diabetes.” Diabetes Care,

vol. 45, Supplement 1, 2022, pp. S65-S73.

American Diabetes Association. (2019). Cardiovascular disease and risk management: standards

of medical care in diabetes—2019. Diabetes care, 42(Supplement 1), S103-S123.

American Diabetes Association. (2019). Diabetes care in the school and day care setting.

Diabetes Care, 42(Suppl 1), S165-S173.

American Diabetes Association. (2021). 10. Cardiovascular Disease and Risk Management:
Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S125-S150.
American Diabetes Association. (2021). 2. Classification and Diagnosis of Diabetes: Standards

of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S15-S33.

American Diabetes Association. (2021). Standards of Medical Care in Diabetes—2021. Diabetes

Care, 44(Supplement 1), S14-S15.

American Diabetes Association. (2022). Diagnosis and Classification of Diabetes Mellitus.

Diabetes Care, 45(Supplement 1), S33-S49.

American Diabetes Association. (2022). Introduction: Standards of Medical Care in Diabetes—

2022. Diabetes Care, 45(Supplement 1), S1–S3. DOI: 10.2337/dc22-S001

American Diabetes Association. (2022). Standards of Medical Care in Diabetes—2022. Diabetes

Care, 45(Supplement 1), S1-S225.

American Diabetes Association. (2022). Standards of Medical Care in Diabetes—2022. Diabetes

Care, 45(Supplement 1), S3-S4.

American Diabetes Association. “Standards of Medical Care in Diabetes.” Diabetes Care 44,

Supplement 1 (2021): S15-S33.

American Diabetes Association. Standards of Medical Care in Diabetes—2020. Diabetes Care

2020 Jan; 43(Supplement 1): S1-S212. DOI: 10.2337/dc20-Sint

Anigbogu, Chikodi, Michael Nweke, and Stanley Onwubiko. “Prevalence and Predictors of

Hypertensive Retinopathy in a Black African Population with Systemic Hypertension.” Cureus

14.1 (2022): e20570.

Aroda VR, Knowler WC, Crandall JP, et al. Metformin for diabetes prevention: insights gained
from the diabetes prevention program/diabetes prevention program outcomes
study. Diabetologia. 2017;60(9):1601–1611
Arrey, W.T., Dimala, C.A., Atashili, J., Mbuagbaw, J. and Monekosso, G.L., 2016. Hypertension,

an emerging problem in rural Cameroon: prevalence, risk factors, and control. International

Journal of Hypertension, 2016.

Bakris, G., Ali, W. F., Parati, G., & ACC/AHA Hypertension Guidelines: Application to Clinical

Practice (2018). ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline

Comparison. Journal of the American College of Cardiology, 72(21), 2585-2596.

Benjamin, E. J., Muntner, P., Alonso, A., & Bittencourt, M. S. (2019). Heart Disease and Stroke

Statistics—2019 Update: A Report from the American Heart Association. Circulation, 139(10),

e56-e528.

Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications.

Nature, 414(6865), 813-820.

Bull, F. C., Al-Ansari, S. S., Biddle, S., Borodulin, K., Buman, M. P., Cardon, G., … &
Willumsen, J. F. (2020). World Health Organization 2020 guidelines on physical activity and
sedentary behaviour. British Journal of Sports Medicine, 54(24), 1451-1462.

Cheung AK, Rahman M, Reboussin DM, et al. Effects of Intensive BP Control in CKD. J Am

Soc Nephrol. 2017;28(9):2812-2823.

Cheung, C. Y., Wong, T. Y., & Lamoureux, E. (2020). The relationship between hypertension and

severity of diabetic retinopathy: a systematic review and meta-analysis. Diabetes Medicine,

37(3), 315-328.

Chinedu, A. and Nicholas, A., 2015. Hypertension prevalence and body mass index correlates
among patients with diabetes mellitus in Oghara, Nigeria. The Nigerian Journal of General
Practice, 13(1), pp.12-15.
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W.,
& Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017
and projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281.
Craig, C. L., Marshall, A. L., Sjöström, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., … &
Oja, P. (2003). International physical activity questionnaire: 12-country reliability and validity.
Medicine & Science in Sports & Exercise, 35(8), 1381-1395.

De Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., … &

Vaidya, A. (2016). Diabetes and hypertension: a position statement by the American Diabetes

Association. Diabetes Care, 39(12), 2065-2079

Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary

syndrome revisited: an update on mechanisms and implications. Endocrine Reviews, 33(6),

981–1030.

Ekelund, U., Steene-Johannessen, J., Brown, W. J., Fagerland, M. W., Owen, N., Powell, K. E.,

… & Lancet Physical Activity Series 2 Executive Committee; Lancet Sedentary Behaviour

Working Group. (2016). Does physical activity attenuate, or even eliminate, the detrimental

association of sitting time with mortality? A harmonised meta-analysis of data from more than

1 million men and women. The Lancet, 388(10051), 1302-1310. DOI: 10.1016/S0140-

6736(16)30370-1

Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type
2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313(6):603–615.
Emdin, C. A., Anderson, S. G., Woodward, M., & Rahimi, K. (2015). Usual blood pressure and
risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of
prospective studies. Journal of the American College of Cardiology, 66(14), 1552-1562.
Eren NK, Harman E, Dolek D, Levent F. Rate of blood pressure control and antihypertensive
treatment approaches in diabetic patients with hypertension. Arch Turk Soc Cardiol.
2014;42(8):733–740.
Florez, J. C. (2019). The Genetics of Type 2 Diabetes: A Review. Diabetes Care, 42(1), 110–119.

Gangwisch, J. E., Feskanich, D., & Malaspina, D. (2014). Sleep Duration and Risk for

Hypertension in Women: Results from the Nurses’ Health Study. Hypertension, 64(2), 517-

523.

Gomez, L., Rodriguez, M., & Martinez, A. (2018). Risk Factors for Hypertension: An Overview

of Current Research. Journal of Clinical Medicine, 7(9), 210.

Hall, J. E., do Carmo, J. M., da Silva, A. A., & Wang, Z. (2019). Obesity-Induced Hypertension:

Interaction of Neurohumoral and Renal Mechanisms. Circulation Research, 124(6), 874-891.

Howard, G., Cushman, M., & Howard, V. J. (2018). Risk Factors for Intracerebral Hemorrhage:

The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke,

49(6), 1363-1368.

International Diabetes Federation. (2019). IDF Diabetes Atlas, 9 th edition. Brussels, Belgium:
International Diabetes Federation.
International Diabetes Federation. (2019). IDF Diabetes Atlas. 9 th ed. Brussels, Belgium:

International Diabetes Federation.

International Diabetes Federation. Eighth Edition 2017. 2017.

Jia, G., & Sowers, J. R. (2021). Hypertension in diabetes: an update of basic mechanisms and

clinical disease. Hypertension, 78(5), 1197-1205.

Judd E, Calhoun DA. Management of resistant hypertension: do not give up on

medication.Nephrol Self Assess Program. 2014; 13:57–63.

Jung, S. H. (2014). Stratified Fisher's exact test and its sample size calculation. Biometrical
Journal, 56(1), 129-140.
Odukoya, O. O., Isikekpei, B. C., Nwaneri, S. C., Akodu, B., Odeniyi, I., Oluwole, E. O.,
&Osuntoki, A. (2024). Co-occurrence of Modifiable Risk Factors for Cardiovascular Disease
 amongst Diabetic Patients in Lagos State, Nigeria. Nigerian Postgraduate Medical
Journal, 31(1), 45-52.

Kemche, B., Saha Foudjo, B. U., & Fokou, E. (2020). Risk factors of hypertension among

diabetic patients from Yaounde central hospital and Etoug-Ebe Baptist health centre,

Cameroon. Journal of Diabetes Research, 2020.

Khan, S. S., Ning, H., & Wilkins, J. T. (2020). Association of Body Mass Index with Lifetime

Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiology, 5(1), 18-

24.

Koliaki, C., Liatis, S., & Kokkinos, A. (2019). Lifestyle Factors and Hypertension: Impact and

Management. Current Hypertension Reports, 21(7), 49.

Kotchen TA. Hypertension control: trends, approaches, and goals. Hypertension. 2007;49(1):19–

20. Doi:10.1161/01.HYP.0000250394.05703.06

Kwak, S. H., Park, K. S., & Lee, M. S. (2021). Genetics of Type 2 Diabetes and Potential

Clinical Implications. Archives of Pharmacal Research, 44(1), 9–23.

Lavery, J. A., Friedman, A. M., Keyes, K. M., Wright, J. D., & Ananth, C. V. (2019). Gestational

diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010.

BJOG: An International Journal of Obstetrics & Gynaecology, 126(10), 1206-1212.

Lee SW, Kim HC, Lee JM, Yun YM, Lee JY, Suh I. Association between changes in systolic

blood pressure and incident diabetes in a community-based cohort study in Korea. Hypertens

Res. 2017;40:710–6.

Lithovius R, Harjutsalo V, Mutter S, Gordin D, Forsblom C, Groop PH; FinnDiane Study Group.

Resistant hypertension and risk of adverse events in individuals with type 1 diabetes: a

Nationwide Prospective Study.Diabetes Care. 2020; 43:1885–1892. Doi: 10.2337/dc20-

Malik, V. S., & Hu, F. B. (2015). Fructose and Cardiometabolic Health: What the Evidence From

Sugar-Sweetened Beverages Tells Us. Journal of the American College of Cardiology, 66(14),

1615–1624.

Meigs, J. B. (2018). The Genetics of Type 2 Diabetes: Insights from the Framingham Study. In

M. A. Feingold, B. Anawalt, A. Boyce et al. (Eds.), Endotext [Internet]. MDText.com, Inc.

Mente, A., O’Donnell, M. J., & Rangarajan, S. (2020). Diet and Hypertension. Annual Review of

Nutrition, 40, 245-271.

Muntner, P., Carey, R. M., Gidding, S., Jones, D. W., Taler, S. J., Wright Jr, J. T., & Whelton, P.
K. (2019). Potential US population impact of the 2017 ACC/AHA high blood pressure
guideline. Journal of the American College of Cardiology, 73(4), 473-484

Nithish C, Prasad RB, Reddy MRRM. Estimation of risk factors for cardio vascular diseases in
urban & semi-urban population: a prospective observational study. International J Med Heal
Res. 2019;2019(5):84–86.
Nouh, F., Omar, M. and Younis, M., 2017. Prevalence of hypertension among diabetic patients in

Benghazi: a study of associated factors. Asian Journal of Medicine and Health, 6(4), pp.1-11.

Nouh, F., Omar, M. and Younis, M., 2017. Prevalence of hypertension among diabetic patients in
Benghazi: a study of associated factors. Asian Journal of Medicine and Health, 6(4), pp.1-11.
Onuoha, F.M. and Egwim, J.I., 2017. Hypertension amongst the diabetic patients assessing care

in a primary care setting in South-Eastern, Nigeria. Journal of diabetes and clinical studies,

1(1), pp.1-6.

Owolabi, E.O., Ter Goon, D., Adeniyi, O.V. and Seekoe, E., 2017. Social epidemiology of
hypertension in Buffalo City Metropolitan Municipality (BCMM): cross-sectional study of
determinants of prevalence, awareness, treatment and control among South African
adults. BMJ open, 7(6), p.e014349.
Parati, G., Stergiou, G. S., Asmar, R., Bilo, G., de Leeuw, P., Imai, Y., … & Myers, M. (2021).

European Society of Hypertension guidelines for blood pressure monitoring at home: a

summary report of the Second International Consensus Conference on Home Blood Pressure

Monitoring. Journal of Hypertension, 39(7), 1278-1285.

Perez-Stable, E. J., Muñoz, R. F., & Van Horn, L. (2019). Genetic and Environmental Influences

on Hypertension. In M. G. Zimetbaum & P. P. Toth (Eds.), Hypertension: A Companion to

Braunwald’s Heart Disease (pp. 29-37). Elsevier.

Pescatello, L. S., Buchner, D. M., & Jakicic, J. M. (2019). Physical Activity to Prevent and Treat

Hypertension: A Systematic Review. Medicine & Science in Sports & Exercise, 51(6), 1314-

1323.

Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018). Diabetes, hypertension, and cardiovascular
disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology, 34(5),
575-584.
Reference: Mayo Clinic. (2021). High blood pressure (hypertension). Retrieved fromSamuel, V.

T., & Shulman, G. I. (2016). The pathogenesis of insulin resistance: integrating signaling

pathways and substrate flux. Journal of Clinical Investigation, 126(1), 12-22. DOI:

10.1172/JCI77812

Sarafidis, P. A. (2018). Hypertension in patients with type 2 diabetes: Targets and management.

International Journal of Hypertension, 2018.

Stefan, N., Häring, H. U., & Hu, F. B. (2013). Metabolically healthy obesity: epidemiology,

mechanisms, and clinical implications. The Lancet Diabetes & Endocrinology, 1(2), 152-162.

DOI: 10.1016/S2213-8587(13)70062-7

Tadesse, K., Amare, H., Hailemariam, T. and Gebremariam, T., 2018. Prevalence of hypertension
among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen
 Mohamed Memorial Hospital Hosanna, Southern Ethiopia. J Diabetes Metab, 9(4), pp.4-10.#
Vargas-uricoechea H, Cáceres-acosta MF. Control of blood pressure and cardiovascular
outcomes in type 2 diabetes. Open Med. 2018;13:304–323.
Tesfaye, S., Boulton, A. J., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., … & Young, M.

J. (2010). Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of

severity, and treatments. Diabetes Care, 33(10), 2285-2293.

Venugopal, K. and Mohammed, M.Z., 2014. Prevalence of hypertension in type-2 diabetes

mellitus. CHRISMED Journal of Health and Research, 1(4), pp.223-227.
Vinik, A. I., Nevoret, M. L., & Casellini, C. (2013). The new age of sudomotor function testing:

a sensitive and specific biomarker for diagnosis, estimation of severity, monitoring

progression, and regression in response to intervention.

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb,
C., … & Wright, J. T. (2018). 2017
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the
prevention, detection, evaluation, and management of high blood pressure in adults: a report of
the American College of Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines. Journal of the American College of Cardiology, 71(19), e127-e248.

WHO. A Global Brief on Hypertension. World Health Organization Press; 2014.

World Health Organization. (2020). WHO guidelines on physical activity and sedentary
behaviour. Geneva: World Health Organization. Retrieved from
https://www.who.int/publications/i/item/9789240015128

World Health Organization. (2021). Noncommunicable diseases. Retrieved from

https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases